Medication info
Zyloric Tablets (Allopurinol)

Zyloric Tablets (Allopurinol)

Prescription medicationTabletOral
Ingredient · strength
Allopurinol›100mg / 1 tablet
Manufacturer / importer
Samil Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 197000050 · Notified 1970.09.25 · Insurance code 643901390

Summary

Main use
Treatment of hyperuricemia, gout, and uric acid nephropathy
Who takes it
Adults
Adult dose
Adults Because a rapid reduction in blood uric acid levels may sometimes trigger an acute gout attack, start with a low dose (allopurinol 100 mg once daily), then increase by 100 mg each week until serum uric acid levels reach 7 mg/100 mL in men and postmenopausal women, or 6 mg/100 mL in premenopausal women. Do not exceed a maximum oral dose of 800 mg daily. In general, administer allopurinol orally after meals in 1~3 divided doses (not exceeding 300 mg per dose): 100 ∼ 300 mg daily for mild gout in adults, 300 ∼ 600 mg daily for moderately severe tophaceous gout, and 600 ∼ 800 mg daily for severe tophaceous gout. In patients with renal failure, reduce the dose according to creatinine clearance: 100 ~ 200 mg daily if creatinine clearance is 10 ~ 20 mL/min, and no more than 100 mg daily if it is below 10 mL/min. Administer in 1 ∼ 3 divided doses or at longer intervals. If plasma oxypurinol levels can be measured, adjust the dose to maintain plasma oxypurinol at 100 μmol/L(15.2 mg/L) or less.

Ingredients

Manufacturer
Samil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hyperuricemia, gout, and uric acid nephropathy

  • Gout
  • hyperuricemia
  • uric acid nephropathy
View approved original text

This medication is used for gout, hyperuricemia, and kidney diseases affected by uric acid.

How to take

Adult dose

Adults Because a rapid reduction in blood uric acid levels may sometimes trigger an acute gout attack, start with a low dose (allopurinol 100 mg once daily), then increase by 100 mg each week until serum uric acid levels reach 7 mg/100 mL in men and postmenopausal women, or 6 mg/100 mL in premenopausal women. Do not exceed a maximum oral dose of 800 mg daily. In general, administer allopurinol orally after meals in 1~3 divided doses (not exceeding 300 mg per dose): 100 ∼ 300 mg daily for mild gout in adults, 300 ∼ 600 mg daily for moderately severe tophaceous gout, and 600 ∼ 800 mg daily for severe tophaceous gout. In patients with renal failure, reduce the dose according to creatinine clearance: 100 ~ 200 mg daily if creatinine clearance is 10 ~ 20 mL/min, and no more than 100 mg daily if it is below 10 mL/min. Administer in 1 ∼ 3 divided doses or at longer intervals. If plasma oxypurinol levels can be measured, adjust the dose to maintain plasma oxypurinol at 100 μmol/L(15.2 mg/L) or less.

Precautions

Serious allergic reactions may occur during use of this medication, so if skin rashes or hypersensitivity symptoms appear, discontinue use immediately. Do not administer to children, nursing mothers, patients with allergies to this medication, or those with a history of severe adverse reactions. Patients with liver or kidney function problems, pregnant women, and the elderly should use this medication cautiously and require regular liver function tests and blood tests. This medication can cause various adverse reactions such as skin rashes, fever, and joint pain; consult a healthcare professional immediately if such symptoms occur. Caution is needed when driving or operating machinery as drowsiness or dizziness may occur. This medication can interact with other drugs, so inform your healthcare provider of any medications you are currently taking. Women who are pregnant or may become pregnant should be cautious when using this medication, and nursing mothers should avoid its use. Safety in children has not been established, and it should not be used except in special cases. Elderly patients may require dose adjustment due to decreased kidney function leading to increased drug concentration. It is recommended to maintain adequate hydration during treatment to increase urine output and alkalinize the urine. Store out of reach of children, and keep the medication in its original container to prevent deterioration in quality. Patients with specific genetic markers have a higher risk of serious skin reactions from this medication, so genetic testing before treatment may be considered. If serious skin reactions or hypersensitivity reactions occur during the use of this medication, discontinue use immediately and consult a healthcare professional.

Side effects

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell's Syndrome), Exfoliative Dermatitis, Hypersensitivity Vasculitis, Eosinophilia, Epidermal Peeling, Fever, Lymphadenopathy, Arthralgia, Hepatitis, Renal Dysfunction, Convulsions, Shock, Anaphylactic-like Symptoms, Aplastic Anemia, Pancytopenia, Agranulocytosis, Hepatic Dysfunction, Jaundice, Renal Failure, Worsening of Renal Failure, Interstitial Nephritis, Interstitial Pneumonia, Myalgia, Asthenia, Increased Creatine Kinase, Elevated Myoglobin in Blood and Urine, Stomatitis, Diarrhea, Convulsions, Anorexia, Abdominal Discomfort, Steatorrhea, Hematemesis, Renal Dysfunction, Taste Disorder, Visual Impairment, Peripheral Neuropathy, Peripheral Neuritis, Headache, Ataxia, Leukopenia, Thrombocytopenia, Hypoplatelet Count, Vascular Immune-associated Lymphoproliferative Disorder, Rash, Vasculitis, Lymphadenitis, Pseudolymphoma, Hepatosplenomegaly, Abnormal Liver Function Tests, Cholestatic Liver Disease, Itching, Cataract, Swelling, Generalized Malaise, Gynecomastia, Dizziness, Hyperlipidemia, Carbuncle, Angina, Hypertension, Bradycardia, Uremia, Hematuria, Angioedema, Hair Loss, Increased Thyroid Stimulating Hormone

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. This helps maintain the effectiveness of the drug and prevents degradation.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

  • QI am advised to drink a lot of water while taking this medication; why is that?

    The product information recommends maintaining adequate hydration to increase urine output and alkalinize the urine while taking this medication. The amount of fluid to drink may vary depending on your health status, so check with the prescribing doctor or pharmacist.

    Answers 1 · 2026.09.14

  • QI received a prescription for gout medication, but I developed a rash while taking it.

    The prescribing information states that if you experience a skin rash or hypersensitivity symptoms while using this medication, you should immediately stop taking it and consult a healthcare professional. It could lead to serious skin reactions, so do not delay and contact the prescribing doctor for guidance.

    Answers 1 · 2026.09.14

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.